Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial.
about
Regular treatment with formoterol for chronic asthma: serious adverse eventsRegular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse eventsFormoterol versus short-acting beta-agonists as relief medication for adults and children with asthmaFormoterol versus short-acting beta-agonists as relief medication for chronic asthmaRegular treatment with formoterol for chronic asthma: serious adverse eventsRegular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse eventsBudesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamolUse of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmaticsProtective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study.Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study.Mild persistent asthma. Traits, treatment set it apart from mild intermittent asthma.Formoterol as reliever medication in asthma: a post-hoc analysis of the subgroup of the RELIEF study in East Asia.Using a combination inhaler (budesonide plus formoterol) as rescue therapy improves asthma control.Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?Formoterol as a rescue medication for asthma.New approaches to managing asthma: a US perspectiveFormoterol dry-powder inhaler for the treatment of asthma and chronic obstructive pulmonary disease.Differences in the pharmacodynamics of budesonide/formoterol and salmeterol/fluticasone reflect differences in their therapeutic usefulness in asthma.Use of dry powder inhalers in acute exacerbations of asthma and COPD.An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.Budesonide/formoterol dry powder in asthma: an option for control as maintenance and reliever therapy.Dry-powder inhalers in acute asthma.A systematic review of adverse drug events associated with administration of common asthma medications in children.Efficacy of inhaled formoterol in reversing bronchoconstriction.Effects of formoterol on contraction and Ca2+ signaling of mouse airway smooth muscle cells.Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma.Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.Risk of pneumonia with budesonide-containing treatments in COPD: an individual patient-level pooled analysis of interventional studies.Is it time for single-inhaler asthma therapy?Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control.Use and safety of long-acting β2-agonists for pediatric asthma
P2860
Q24200353-AD565064-0106-4550-82EF-3626999FC2FDQ24202005-8E286F69-8CED-4CC1-9BA8-5A6084F1AB8CQ24235496-3E70095F-CD74-4E5A-8218-72034B58FB39Q24239826-54B5FF91-9235-4C44-874C-06A0BCC10F59Q24241250-7192FA06-B276-46AF-BB22-48E1B8AF78E3Q24241453-FEBA9C50-C646-412E-8732-EDD35787D860Q25255803-3A0D646E-FF25-4774-9A06-51415BBC2FB3Q28066822-8AD3BBDC-42C4-4FB5-B0BF-D4C0DE0D7D7AQ33934063-03AC24BD-1728-404D-96AB-207340C14A39Q34573003-FDEB3F19-5612-402C-B14A-1D212CCC889EQ35788549-D18086FD-B2BF-4100-BFDE-62A4526BE7D1Q35892015-A0A97E3A-9839-4003-9B0C-376874ACCFD8Q35981019-39F2BB0D-F643-4D0F-8F99-E3B62AAFA85DQ36288427-E1AB8012-8FA3-433E-891E-E3F334AA62EEQ36655201-8426AC3B-288F-43D8-B2BE-52789B5CA474Q36823534-D17AB88A-4FB5-4995-AE48-4EEC7AF366FCQ37000770-1F72335B-0C94-4C94-97D6-334784393EC6Q37362634-D0DDAB7D-B52E-48DF-B93D-50184E63D285Q37483073-691F0882-5AC3-4D68-8BF4-AAC1D1B9C0C0Q37522916-E8584425-0691-46A0-BE24-DD2100CDAF0BQ37556546-68A98E36-0CBB-4729-B3D8-60D9091E021CQ37678433-24A03148-09F5-4DED-BA76-4BC0DC569414Q38171566-98C5791F-C14E-4711-972D-67FC94122F7AQ38632045-932E13E4-2C44-4ECA-8541-87EA7695C240Q39340262-8ECD9D5F-C77F-4D87-97E0-1A445CBDDAA1Q39342566-0C292F2B-55F6-43FA-B1A0-B26B6854216FQ39374605-BD8B8AB0-A680-4A57-A9A6-C373E8BA830AQ39615961-4C2C9DF6-110A-465A-A941-0D9BA7798773Q42124677-5C2A3376-1060-4A8B-B8B3-EA380EBC0663Q42984977-0E280B40-BD4B-4010-8658-18EDF81005C5Q44765635-B85509A4-341B-4741-BDC4-85D8508E455CQ57821604-57BDA381-E327-4D98-BCA4-CC6BB096EE22
P2860
Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial.
@en
Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial.
@nl
type
label
Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial.
@en
Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial.
@nl
prefLabel
Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial.
@en
Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial.
@nl
P2093
P1476
Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial.
@en
P2093
C Villasante
M Campbell
R A Pauwels
RELIEF Study investigators
T Bengtsson
P304
P356
10.1183/09031936.03.00055803
P577
2003-11-01T00:00:00Z